高级检索
当前位置: 首页 > 详情页

Potent Antibody Response Elicited by a Third Booster Dose of Inactivated COVID-19 Vaccine in Healthy Subjects

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China [2]The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China [3]Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China [4]Guangdong Provincial Center for Disease Control and Prevention, Guangdong Workstation for Emerging Infectious Disease Controland Prevention, Guangzhou, China [5]Emergency Department, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China [6]Research and Development Centers, and 7Department of Medical Affairs, Autobio Diagnostics Co.Ltd.,Zhengzhou, China [7]Guangdong Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou, China [8]Department of Pulmonary and Critical Care Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China
出处:
ISSN:

关键词: SARS-CoV-2 inactivated SARS-CoV-2 vaccine antibody response booster vaccination neutralizing antibody

摘要:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been used worldwide on a large scale because of its potent ability to contain the coronavirus disease 2019 (COVID-19) pandemic, and the antibody response induced by the vaccine needs to be elucidated. Thus, we conducted a prospective trial in healthy subjects to observe the antibody response after three doses of inactivated vaccines. Our results showed that neutralizing antibody (NAb) levels were significantly higher after the booster vaccination compared to the second, a 4.9-fold increase, with the peak occurring at 28 days. The NAb level could be maintained for a longer period after the third vaccination, with higher levels still observed after 3 months. We did not observe significantly higher levels of SARS-CoV-2 spike-specific immunoglobulin G (S-IgG) and immunoglobulin M (IgM) after the third vaccination compared with the second vaccination; this was especially true for SARS-CoV-2 spike-specific immunoglobulin M (S-IgM), which was barely expressed. Notably, those who did not undergo NAb seroconversion after two doses of the vaccine produced high and long-lasting NAb after the third vaccination, confirming that they were not completely unresponsive to the vaccine. The NAb titer in younger subjects (aged 20-40 years) rose 3.4-fold compared with older subjects (aged 40-60 years) after the second vaccination, but the difference was narrowed after the third vaccination (2.8-fold increase). In addition, the levels of antibodies in older men were 3.4-fold lower than those in the older women after the third vaccination. Overall, this study elucidates the dynamic change in antibodies after three doses of vaccination, which provides a reference for the improvement of vaccination strategies.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 4 区 医学
小类 | 4 区 免疫学 4 区 病毒学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 免疫学 4 区 病毒学
第一作者:
第一作者机构: [1]Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China [*1]Department of Laboratory Medicine Shunde Hospital of Guangzhou University of Chinese Medicine No. 12 Jinsha Avenue Shunde District Foshan 528300 Guangdong Province China [*2]Department of Pulmonary and Critical Care Medicine Shunde Hospital of Guangzhou University of Chinese Medicine Foshan 528300 Guangdong Province China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号